(PIPR) Piper Sandler Companies - Ratings and Ratios
Investment Banking, Equity Trading, Fixed Income, Advisory Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.68% |
| Yield on Cost 5y | 6.48% |
| Yield CAGR 5y | 15.02% |
| Payout Consistency | 88.2% |
| Payout Ratio | 36.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 33.0% |
| Value at Risk 5%th | 51.7% |
| Relative Tail Risk | -4.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -7.45 |
| CAGR/Max DD | 0.99 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.462 |
| Beta | 1.448 |
| Beta Downside | 1.410 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.78% |
| Mean DD | 8.82% |
| Median DD | 6.51% |
Description: PIPR Piper Sandler Companies November 06, 2025
Piper Sandler Companies (NYSE:PIPR) is a full-service investment bank and institutional securities firm that provides a suite of services-including investment banking, equity and fixed-income sales & trading, research, and advisory (M&A, capital raising, restructuring, and municipal finance)-to corporations, private-equity sponsors, public entities, non-profits, and institutional investors across the United States and abroad.
In FY 2023 the firm generated roughly $2.3 billion in revenue, with investment-banking fees accounting about 45 % of that total, while its alternative-asset platforms in merchant banking and healthcare contributed a modest but growing share of earnings. The business is sensitive to the prevailing interest-rate cycle: a higher-for-longer rate environment tends to boost fixed-income trading volumes and municipal-bond issuance, yet can compress M&A activity if borrowing costs rise. Additionally, the ongoing U.S. infrastructure push and state-level education/healthcare spending are key secular drivers for Piper Sandler’s public-finance franchise.
If you want a deeper, data-driven look at how these dynamics translate into valuation metrics, a quick dive into ValueRay’s analyst toolkit can be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (236.4m TTM) > 0 and > 6% of Revenue (6% = 100.3m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -28.59pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 36.47% (prev 32.63%; Δ 3.84pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 20.7m <= Net Income 236.4m (YES >=105%, WARN >=100%) |
| Net Debt (660.0k) to EBITDA (294.4m) ratio: 0.00 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.8m) change vs 12m ago 0.22% (target <= -2.0% for YES) |
| Gross Margin 99.69% (prev 99.54%; Δ 0.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 78.65% (prev 72.83%; Δ 5.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 51.76 (EBITDA TTM 294.4m / Interest Expense TTM 5.18m) >= 6 (WARN >= 3) |
Altman Z'' 4.45
| (A) 0.27 = (Total Current Assets 711.6m - Total Current Liabilities 101.8m) / Total Assets 2.22b |
| (B) 0.28 = Retained Earnings (Balance) 629.8m / Total Assets 2.22b |
| (C) 0.13 = EBIT TTM 267.9m / Avg Total Assets 2.13b |
| (D) 0.84 = Book Value of Equity 632.4m / Total Liabilities 756.7m |
| Total Rating: 4.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.14
| 1. Piotroski 4.50pt |
| 2. FCF Yield -0.32% |
| 3. FCF Margin -1.14% |
| 4. Debt/Equity 0.09 |
| 5. Debt/Ebitda 0.00 |
| 6. ROIC - WACC (= 5.28)% |
| 7. RoE 19.09% |
| 8. Rev. Trend 6.85% |
| 9. EPS Trend 10.47% |
What is the price of PIPR shares?
Over the past week, the price has changed by -6.98%, over one month by +8.33%, over three months by -3.84% and over the past year by +11.09%.
Is PIPR a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the PIPR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 391 | 15% |
| Analysts Target Price | 391 | 15% |
| ValueRay Target Price | 444.8 | 30.8% |
PIPR Fundamental Data Overview December 16, 2025
P/E Trailing = 26.741
P/S = 3.4503
P/B = 4.6192
Beta = 1.543
Revenue TTM = 1.67b USD
EBIT TTM = 267.9m USD
EBITDA TTM = 294.4m USD
Long Term Debt = 99.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 15.0m USD (from shortTermDebt, last quarter)
Debt = 114.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 660.0k USD (from netDebt column, last quarter)
Enterprise Value = 5.93b USD (5.93b + Debt 114.7m - CCE 114.0m)
Interest Coverage Ratio = 51.76 (Ebit TTM 267.9m / Interest Expense TTM 5.18m)
FCF Yield = -0.32% (FCF TTM -19.1m / Enterprise Value 5.93b)
FCF Margin = -1.14% (FCF TTM -19.1m / Revenue TTM 1.67b)
Net Margin = 14.14% (Net Income TTM 236.4m / Revenue TTM 1.67b)
Gross Margin = 99.69% ((Revenue TTM 1.67b - Cost of Revenue TTM 5.18m) / Revenue TTM)
Gross Margin QoQ = 99.82% (prev 99.54%)
Tobins Q-Ratio = 2.67 (Enterprise Value 5.93b / Total Assets 2.22b)
Interest Expense / Debt = 0.71% (Interest Expense 818.0k / Debt 114.7m)
Taxrate = 23.22% (24.9m / 107.4m)
NOPAT = 205.7m (EBIT 267.9m * (1 - 23.22%))
Current Ratio = 6.99 (Total Current Assets 711.6m / Total Current Liabilities 101.8m)
Debt / Equity = 0.09 (Debt 114.7m / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = 0.00 (Net Debt 660.0k / EBITDA 294.4m)
Debt / FCF = -0.03 (negative FCF - burning cash) (Net Debt 660.0k / FCF TTM -19.1m)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.65% (Net Income 236.4m / Total Assets 2.22b)
RoE = 19.09% (Net Income TTM 236.4m / Total Stockholder Equity 1.24b)
RoCE = 20.02% (EBIT 267.9m / Capital Employed (Equity 1.24b + L.T.Debt 99.7m))
RoIC = 16.43% (NOPAT 205.7m / Invested Capital 1.25b)
WACC = 11.14% (E(5.93b)/V(6.04b) * Re(11.35%) + D(114.7m)/V(6.04b) * Rd(0.71%) * (1-Tc(0.23)))
Discount Rate = 11.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.26%
Fair Price DCF = unknown (Cash Flow -19.1m)
EPS Correlation: 10.47 | EPS CAGR: -17.45% | SUE: 1.47 | # QB: 4
Revenue Correlation: 6.85 | Revenue CAGR: -8.13% | SUE: 1.20 | # QB: 2
EPS next Quarter (2026-03-31): EPS=4.04 | Chg30d=-0.035 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=18.60 | Chg30d=+0.800 | Revisions Net=+0 | Growth EPS=+19.4% | Growth Revenue=+14.9%
Additional Sources for PIPR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle